Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Elvan is active.

Publication


Featured researches published by A. Elvan.


Journal of Human Hypertension | 2014

Blood pressure changes after renal denervation at 10 European expert centers

Alexandre Persu; Yu Jin; Michel Azizi; Marie Baelen; Sebastian Völz; A. Elvan; Francesca Severino; Ján Rosa; Ahmet Adiyaman; Fadl Elmula M. Fadl Elmula; Alison Taylor; Antoinette Pechère-Bertschi; Grégoire Wuerzner; Fadi Jokhaji; Thomas Kahan; Jean Renkin; M Monge; Petr Widimský; Lotte Jacobs; Michel Burnier; Patrick B. Mark; Sverre E. Kjeldsen; Bert Andersson; Marc Sapoval; Jan A. Staessen

We did a subject-level meta-analysis of the changes (Δ) in blood pressure (BP) observed 3 and 6 months after renal denervation (RDN) at 10 European centers. Recruited patients (n=109; 46.8% women; mean age 58.2 years) had essential hypertension confirmed by ambulatory BP. From baseline to 6 months, treatment score declined slightly from 4.7 to 4.4 drugs per day. Systolic/diastolic BP fell by 17.6/7.1u2009mmu2009Hg for office BP, and by 5.9/3.5, 6.2/3.4, and 4.4/2.5u2009mmu2009Hg for 24-h, daytime and nighttime BP (P⩽0.03 for all). In 47 patients with 3- and 6-month ambulatory measurements, systolic BP did not change between these two time points (P⩾0.08). Normalization was a systolic BP of <140u2009mmu2009Hg on office measurement or <130u2009mmu2009Hg on 24-h monitoring and improvement was a fall of ⩾10u2009mmu2009Hg, irrespective of measurement technique. For office BP, at 6 months, normalization, improvement or no decrease occurred in 22.9, 59.6 and 22.9% of patients, respectively; for 24-h BP, these proportions were 14.7, 31.2 and 34.9%, respectively. Higher baseline BP predicted greater BP fall at follow-up; higher baseline serum creatinine was associated with lower probability of improvement of 24-h BP (odds ratio for 20-μmolu2009l−1 increase, 0.60; P=0.05) and higher probability of experiencing no BP decrease (OR, 1.66; P=0.01). In conclusion, BP responses to RDN include regression-to-the-mean and remain to be consolidated in randomized trials based on ambulatory BP monitoring. For now, RDN should remain the last resort in patients in whom all other ways to control BP failed, and it must be cautiously used in patients with renal impairment.


The Annals of Thoracic Surgery | 2004

Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgery: six years experience

Hauw T. Sie; Willem P. Beukema; A. Elvan; Anand R. Ramdat Misier

BACKGROUNDnThe Cox maze procedure is considered an effective surgical treatment of atrial fibrillation in patients with and without organic heart disease. Radiofrequency energy offers an alternative to the complex surgical maze procedure. We used the radiofrequency modified maze III procedure in patients with atrial fibrillation undergoing elective concomitant cardiac surgery. This study evaluated the long-term results of the irrigated radiofrequency ablation to create linear lines of conduction block endocardially.nnnMETHODSnBetween November 1995 and June 2001, 200 patients with mainly structural heart disease and chronic atrial fibrillation underwent intraoperative radiofrequency linear ablation in both atria with concomitant cardiac surgery.nnnRESULTSnThe in-hospital mortality rate was 3.5% (7 patients) and during the mean follow-up of 40 months (range, 12 to 80) 27 patients (13.5%) died. Eight patients (4%) were lost from follow-up and complete data were available in 158 survivors. Sinus or atrial rhythm was present in 116 patients (73.4%) and an atrial driven rhythm in 10 patients (6.3%) with an atrioventricular pacemaker. Atrial fibrillation or flutter was documented in 32 patients (20.3%). Antiarrhythmic drugs were used in 49% of survivors who were free of atrial fibrillation or flutter.nnnCONCLUSIONSnIntraoperative radiofrequency endocardial ablation is an effective technique to eliminate atrial fibrillation with promising long-term results.


European Journal of Cardio-Thoracic Surgery | 2001

The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery

Hauw T. Sie; Willem P. Beukema; Anand R. Ramdat Misier; A. Elvan; Jacob J. Ennema; Hein J.J. Wellens

OBJECTIVEnPatients with mitral valve disease and suffering of atrial fibrillation of more than 1 years duration have a low probability of remaining in sinus rhythm after valve surgery alone. Intraoperative radiofrequency ablation was used as an alternative to simplify the surgical maze procedure.nnnMETHODSnSeventy-two patients with mitral valve disease, aged 63+/-11 years ranging from 31 to 80 years, underwent valve surgery and radiofrequency energy applied endocardially, based on the maze III procedure to eliminate the arrhythmia. The right-sided maze was performed on the beating heart and the left-sided maze during aorta cross-clamping.nnnRESULTSnSurgical procedures included mitral valve repair (n=38) or replacement (n=34) and in addition tricuspid valve repair (n=42), closure of an atrial septal defect (n=2) and correction of cor triatriatum (n=1). The left-sided maze needed 14+/-3 min extra ischemic time. There were two in-hospital deaths (2.7%) and three patients (4.2%) died during follow-up of 20+/-15 months. Among 67 surviving patients, 51 patients (76%) were in sinus rhythm, two patients (3%) had an atrial rhythm and eight patients (12%) had persistent atrial fibrillation or atrial flutter. Four patients had a pacemaker implanted, in one patient because of sinus node dysfunction. Doppler echocardiography in 64 patients demonstrated right atrial contractility in 89% and left atrial transport in 91% of patients.nnnCONCLUSIONSnIntraoperative radiofrequency ablation of atrial fibrillation is an effective and less invasive alternative for the original maze procedure to eliminate atrial fibrillation.


European Heart Journal | 2016

Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial.

Karl-Heinz Kuck; Alexander Fürnkranz; K.R. Julian Chun; Andreas Metzner; Feifan Ouyang; Michael Schlüter; A. Elvan; Hae W. Lim; Fred Kueffer; Thomas Arentz; Jean Paul Albenque; Claudio Tondo; Michael Kühne; Christian Sticherling; Josep Brugada

Abstract Aims The primary safety and efficacy endpoints of the randomized FIRE AND ICE trial have recently demonstrated non-inferiority of cryoballoon vs. radiofrequency current (RFC) catheter ablation in patients with drug-refractory symptomatic paroxysmal atrial fibrillation (AF). The aim of the current study was to assess outcome parameters that are important for the daily clinical management of patients using key secondary analyses. Specifically, reinterventions, rehospitalizations, and quality-of-life were examined in this randomized trial of cryoballoon vs. RFC catheter ablation. Methods and results Patients (374 subjects in the cryoballoon group and 376 subjects in the RFC group) were evaluated in the modified intention-to-treat cohort. After the index ablation, log-rank testing over 1000 days of follow-up demonstrated that there were statistically significant differences in favour of cryoballoon ablation with respect to repeat ablations (11.8% cryoballoon vs. 17.6% RFC; P = 0.03), direct-current cardioversions (3.2% cryoballoon vs. 6.4% RFC; P = 0.04), all-cause rehospitalizations (32.6% cryoballoon vs. 41.5% RFC; P = 0.01), and cardiovascular rehospitalizations (23.8% cryoballoon vs. 35.9% RFC; P < 0.01). There were no statistical differences between groups in the quality-of-life surveys (both mental and physical) as measured by the Short Form-12 health survey and the EuroQol five-dimension questionnaire. There was an improvement in both mental and physical quality-of-life in all patients that began at 6 months after the index ablation and was maintained throughout the 30 months of follow-up. Conclusion Patients treated with cryoballoon as opposed to RFC ablation had significantly fewer repeat ablations, direct-current cardioversions, all-cause rehospitalizations, and cardiovascular rehospitalizations during follow-up. Both patient groups improved in quality-of-life scores after AF ablation. Clinical trial registration ClinicalTrials.gov identifier: NCT01490814.


Netherlands Heart Journal | 2007

Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally

J. K. Jongman; N. Jepkes-Bruin; A. R. Ramdat Misier; W. P. Beukema; P. P. H. M. Delnoy; H. Oude Luttikhuis; Jan-Henk E. Dambrink; Jan C.A. Hoorntje; A. Elvan

Brugada syndrome is an inherited cardiac disease and is associated with a peculiar pattern on the electrocardiogram and an increased risk of sudden death. Electrical storm is a malignant but rare phenomenon in symptomatic patients with Brugada syndrome. We describe a patient who presented with repetitive ICD discharges during two episodes of recurrent VF. After the initiation of isoproterenol infusion and oral quinidine, the ventricular tachyarrhythmias were successfully suppressed. (Neth Heart J 2007;15:151-4.)


Journal of the American College of Cardiology | 2001

Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation.

Hemanth Ramanna; A. Elvan; Fred H.M. Wittkampf; Jacques M.T. de Bakker; Richard N.W. Hauer; Etienne O. Robles de Medina

OBJECTIVESnThe objective was to assess the effect ofverapamil on atrial fibrillation (AF) cycle length and spatial dispersion of refractoriness in patients with chronic AF.nnnBACKGROUNDnPrevious studies have suggested that verapamil prevents acute remodeling by AF. The effects of verapamil in chronic AF are unknown.nnnMETHODSnDuring electrophysiologic study in 15 patients with chronic AF (duration >1 year), 12 unipolar electrograms were recorded from right atrial free wall, right atrial appendage and coronary sinus, along with monophasic action potential recordings from the right atrial appendage. The mean fibrillatory interval at each atrial recording site was used as an index for local refractoriness. Dispersion of refractoriness was calculated as the standard deviation of all local mean fibrillatory intervals expressed as a percentage of the overall mean fibrillatory interval. After baseline measurements, verapamil (0.075 mg/kg intravenous in 10 min) was infused and the measurements were repeated.nnnRESULTSnAfter administration ofverapamil, mean fibrillatory intervals shortened by a mean of 16.6 +/- 3.3 ms (p < 0.001) at the right free wall, 15.0 +/- 3.5 ms (p < 0.001) at the appendage and 17.1 +/- 3.2 ms (p < 0.01) in the coronary sinus. Monophasic action potential duration decreased by 15.9 +/- 4.0 ms (p < 0.01). Dispersion of refractoriness increased in all patients from 3.8 +/- 0.8 to 5.1 +/- 1.8 (p < 0.001). A strong correlation between mean fibrillatory intervals and action potential duration was found, both before and after verapamil.nnnCONCLUSIONSnVerapamil caused shortening of refractoriness and increase in spatial dispersion of refractoriness in patients with chronic AF. This implies that verapamil is not useful in reversing the remodeling process in these patients.


American Heart Journal | 2008

Clinical response of cardiac resynchronization therapy in the elderly

Peter Paul H.M. Delnoy; Jan Paul Ottervanger; Henk Oude Luttikhuis; A. Elvan; Anand R. Ramdat Misier; W. P. Beukema; Norbert M. van Hemel

BACKGROUNDnAlthough prevalence of heart failure increases with age, in most clinical trials of cardiac resynchronization therapy (CRT), older patients are not included. Observational studies of effects of CRT in older patients had a small sample size. In the present study, the clinical and echocardiographic response to CRT in a larger group of elderly (age > 75 years) patients was evaluated.nnnMETHODSnIn this prospective observational study of 266 consecutive patients, CRT was performed in 107 elderly patients (40%) and 159 (60%) younger patients (age < or = 75 years). Echocardiographic and clinical parameters were evaluated at baseline and at 3, 12, and 24 months.nnnRESULTSnIn the elderly group, mean age was 79 years compared with 67 years in patients aged < or = 75 years. Clinical baseline characteristics between the 2 groups were comparable. During follow-up, there was a comparable and sustained improvement in both groups according to New York Heart Association (NYHA) class, quality of life score, and left ventricular (LV) ejection fraction. Clinical response, defined as survival with improvement (> or = 1 score) of NYHA class without hospital admittance for heart failure, was seen in 67% and 69% (group aged < or = 75 years) versus 65% and 60% (group aged > 75 years) after 3 months and 1 year, respectively. Reverse LV remodeling defined as LV end-systolic volume reduction > or = 10% was seen in 79% and 87% (group aged < or = 75 years) versus 71% and 79% (group aged > 75 years) after 3 months and 1 year, respectively. Hospitalization for heart failure decreased significantly in both groups in the year after CRT. A subgroup analysis of 39 octogenarians (> 80 years) also showed a significant improvement in NYHA class and LV ejection fraction in this subgroup. Also, LV reverse remodeling occurred in a similar extent (75% and 84%) after 3 months and 1 year, respectively.nnnCONCLUSIONSnThis study shows a clinical and echocardiographic improvement of CRT in patients aged > 75 years and even so in octogenarians.


Journal of Human Hypertension | 2015

Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study

Pim Gal; M. R de Jong; Jaap Jan J. Smit; A Adiyaman; Jan A. Staessen; A. Elvan

During renal sympathetic denervation (RDN), no mapping of renal nerves is performed and there is no clear end point of RDN. We hypothesized high-frequency renal nerve stimulation (RNS) may increase blood pressure (BP), and this increase is significantly blunted after RDN. The aim of this study was to determine the feasibility of RNS in patients undergoing RDN. Eight patients with resistant hypertension undergoing RDN were included. A quadripolar catheter was positioned at four different sites in either renal artery. RNS was performed during 1u2009min with a pacing frequency of 20u2009Hz. After all patients successfully underwent RDN, RNS was repeated at the site of maximum BP response before RDN in either renal artery. Mean age was 66 years. During RNS, BP increased significantly from 108/55 to 132/68u2009mmu2009Hg (P<0.001). After RDN, systolic BP response at the site of maximum response to RNS was significantly blunted (+43.1 vs +9.3u2009mmu2009Hg, P=0.002). In three patients, a systolic BP increase >10u2009mmu2009Hg was observed after RDN. In conclusion, RNS resulted in an acute temporary BP increase. This response was significantly blunted after RDN. RNS may potentially serve as an end point for RDN.


Journal of Hypertension | 2014

Hyperresponders vs. nonresponder patients after renal denervation: do they differ?

Alexandre Persu; Michel Azizi; Yu Jin; Sebastian Völz; Ján Rosa; Fadl Elmula M. Fadl Elmula; Antoinette Pechère-Bertschi; Michel Burnier; Patrick B. Mark; A. Elvan; Jean Renkin; Marc Sapoval; Thomas Kahan; Sverre E. Kjeldsen; Jan A. Staessen

Background: Blood pressure (BP) response after renal denervation (RDN) is highly variable. Besides baseline BP, no reliable predictors of response have been consistently identified. The differences between patients showing a major BP decrease after RDN vs. nonresponders have not been studied so far. Aim and methods: We identified extreme BP responders (first quintile) and nonresponders (fifth quintile) to RDN defined according to office or 24-h ambulatory BP in the European Network COordinating research on Renal Denervation database (nu200a=u200a109) and compared the baseline characteristics and BP changes 6 months after RDN in both subsets. Results: In extreme responders defined according to ambulatory BP, baseline BP and BP changes 6 months after RDN were similar for office and out-of-the office BP. In contrast, extreme responders defined according to office BP were characterized by a huge white-coat effect at baseline, with dramatic shrinkage at 6 months. Compared with nonresponders, extreme responders defined according to office BP were more frequently women, had higher baseline office – but not ambulatory – BP, and higher estimated glomerular filtration rate (eGFR). In contrast, when considering ambulatory BP decrease to define extreme responders and nonresponders, the single relevant difference between both subsets was baseline ambulatory BP. Conclusion: This study suggests a major overestimation of BP response after RDN in extreme responders defined according to office, but not ambulatory BP. The association of lower eGFR with poor response to RDN is consistent with our previous analysis. The increased proportion of women in extreme responders may reflect sex differences in drug adherence.


European Heart Journal | 2008

Pressure–volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites

Peter Paul H.M. Delnoy; Jan Paul Ottervanger; Henk Oude Luttikhuis; Dick Hs Vos; A. Elvan; Anand R. Ramdat Misier; W. P. Beukema; Paul Steendijk; Norbert M. van Hemel

AIMSnTo evaluate the clinical utility of pressure-volume loop analyses during pacemaker/implantable cardioverter defibrillator (ICD) implantations to assess the optimal right ventricular (RV) and/or left ventricular (LV) lead position.nnnMETHODS AND RESULTSn29 patients with heart failure and chronic RV apical pacing were studied. Stroke work (SW), LV ejection fraction (LVEF), cardiac output (CO), and LV dP/dt(max) were assessed using a conductance catheter in the LV during RV apical, RV outflow tract, single-site LV, and biventricular pacing at different left-sided pacing locations. Left ventricular ejection fraction was 34.3 +/- 9.8%. Compared with baseline, RV outflow tract pacing showed a small increase of 4.0 +/- 6.4% in LV dP/dt(max) and no improvement in SW, LVEF, or CO. In the optimal biventricular configuration, SW increased 39 +/- 41%, LVEF increased 22 +/- 13%, CO increased 16 +/- 16%, and LV dP/dt(max) increased 10 +/- 11% (all P < 0.05). In 45% of the patients, the optimal LV lead position was found at a different location as the first choice postero-lateral or lateral target vein.nnnCONCLUSIONnPressure-volume loop analysis during pacemaker/ICD implantations facilitates to determine the optimal LV pacing site. Patients with chronic RV pacing showed a significant acute improvement in LV function when LV pacing or biventricular pacing is applied.

Collaboration


Dive into the A. Elvan's collaboration.

Top Co-Authors

Avatar

Ahmet Adiyaman

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan A. Staessen

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Alexandre Persu

Cliniques Universitaires Saint-Luc

View shared research outputs
Top Co-Authors

Avatar

Jean Renkin

Cliniques Universitaires Saint-Luc

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lotte Jacobs

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge